26 February 2016
Here at Chris O`Brien Lifehouse, the Hon. Mike Baird MP, Premier of New South Wales, and the Hon. Pru Goward MP, NSW Minister for Medical Research, have launched a new trial involving eligible patients taking cannabis-plant derived medicines in capsule form to combat nausea caused by chemotherapy.
Currently many people who undergo chemotherapy will respond well to standard treatments for preventing symptoms of nausea and vomiting that can accompany this important cancer treatment. We know, though, that up to one-third of patients receiving potent intravenous chemotherapy do not have complete symptom relief.
The aim of this $2.8M clinical trial, funded by the NSW Government through The University of Sydney, is to determine if administering a capsule containing cannabis-derived medicine will reduce nausea and vomiting during and after intravenous chemotherapy for cancer.
The cannabis-derived medicine will be administered in capsules that have been formulated with a balance of cannabinoids to attempt to minimise side effects, while retaining and strengthening the anti-nausea properties of cannabis. It is planned that if a smaller scale trial shows promise and acceptable tolerability, that it will lead to the largest and most definitive clinical trial ever of medical cannabis products for this indication.
The research team involves leading Australian researchers in cancer, addiction medical and clinical toxicology. It is led by Clinical Associate Professor Peter Grimison from Chris O’Brien Lifehouse, in partnership with researchers from the NHMRC Clinical Trials Centre and Lambert Initiative at the University of Sydney, Sydney Local Health District and other leading hospitals in NSW.
For more information, including how to get on the trial:
call the Cannabis Trials Help Line on 1800 217 257
write to Cannabis Trials, NSW Ministry of Health, Locked Mail Bag 961, North Sydney, NSW 2059
email the NSW Ministry of Health on firstname.lastname@example.org